Perrigo Appoints New Independent Directors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 53 minutes ago
0mins
Source: PRnewswire
- New Board Members: Perrigo Company appointed Salman Amin and Omer Gajial as independent directors effective June 30, 2026, aiming to leverage their extensive experience in consumer products and retail to advance the company's strategic priorities.
- Salman Amin's Background: Amin has over 30 years of experience in the global consumer products industry, having served as CEO of pladis Global, where he successfully led a multi-year transformation that resulted in sustained revenue growth and improved profitability.
- Omer Gajial's Background: Gajial is currently the CEO of GoTo Foods, overseeing more than 7,000 restaurant and retail locations globally, and previously held the position of Executive Vice President at Albertsons Companies, focusing on merchandising and digital initiatives.
- Strategic Implications: The addition of these directors not only strengthens Perrigo's leadership in the consumer health sector but also enhances the company's strategic implementation in digital transformation and market growth, thereby improving overall operational efficiency.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PRGO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PRGO
Wall Street analysts forecast PRGO stock price to rise
3 Analyst Rating
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 10.050
Low
18.00
Averages
20.33
High
23.00
Current: 10.050
Low
18.00
Averages
20.33
High
23.00
About PRGO
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Perrigo Appoints New Independent Directors
- New Board Members: Perrigo Company appointed Salman Amin and Omer Gajial as independent directors effective June 30, 2026, aiming to leverage their extensive experience in consumer products and retail to advance the company's strategic priorities.
- Salman Amin's Background: Amin has over 30 years of experience in the global consumer products industry, having served as CEO of pladis Global, where he successfully led a multi-year transformation that resulted in sustained revenue growth and improved profitability.
- Omer Gajial's Background: Gajial is currently the CEO of GoTo Foods, overseeing more than 7,000 restaurant and retail locations globally, and previously held the position of Executive Vice President at Albertsons Companies, focusing on merchandising and digital initiatives.
- Strategic Implications: The addition of these directors not only strengthens Perrigo's leadership in the consumer health sector but also enhances the company's strategic implementation in digital transformation and market growth, thereby improving overall operational efficiency.
See More
Perrigo Appoints New Independent Directors
- New Board Members: Perrigo Company announced the appointment of Salman Amin and Omer Gajial as independent directors effective June 30, 2026, aiming to leverage their extensive experience in consumer products and retail to advance the company's strategic priorities.
- Salman Amin's Background: Mr. Amin brings over 30 years of experience in the global consumer products industry, having served as CEO of pladis Global, where he successfully led a multi-year transformation that resulted in sustained revenue growth and improved profitability.
- Omer Gajial's Experience: Mr. Gajial, currently CEO of GoTo Foods, has extensive experience in retail and e-commerce, previously serving as Executive Vice President at Albertsons Companies, which positions him to provide strategic insights for Perrigo.
- Strategic Implications: The addition of these new directors not only strengthens Perrigo's leadership team but also aims to drive innovation and growth in the OTC self-care market, further solidifying its market position in North America and Europe.
See More
Stryker Shares Surge 5.3% on Analyst Upgrade and Growth Prospects
- Significant Price Surge: Stryker (SYK) shares rose 5.3% in the last trading session to close at $332.71, with trading volume significantly exceeding normal levels, reflecting renewed investor optimism regarding the company's long-term growth prospects.
- Analyst Upgrade: A recent upgrade to 'Outperform' by analysts has bolstered investor confidence, alongside management's reaffirmation of full-year guidance, indicating a recovery from temporary cyber disruptions.
- Strong Earnings Expectations: Stryker is expected to report quarterly earnings of $3.49 per share, representing an 11.5% year-over-year increase, with revenues projected at $6.56 billion, up 8.9%, highlighting the company's robust performance in the medical device sector.
- Earnings Estimate Revision: Although the consensus EPS estimate has been slightly revised lower, the correlation between earnings estimate trends and stock price movements suggests that investors should monitor SYK's future performance to determine if this price increase can be sustained.
See More
Market Analysis: Stock Performance and Investment Recommendations
- Stock Performance Analysis: Constellation Energy's stock has significantly declined, with analysts recommending a 'buy' as they believe the price has fallen too low, potentially offering a good entry point for investors.
- Investment Recommendation: Credo Technology is described as an 'excellent networking company,' with analysts suggesting to hold and gradually reduce cost basis, indicating its stock is on a rapid upward trajectory with substantial future potential.
- Market Sentiment: ManpowerGroup's performance has not been satisfactory, with analysts stating it has 'never really been a great win,' reflecting a lack of confidence in the company that may impact its future stock price.
- Value Trap Warning: Perrigo is viewed as a 'value trap,' with analysts noting a lack of growth potential and advising caution, which could lead to capital outflows from the stock.
See More
Perrigo Appoints New CEO to Maintain 2026 Outlook
- Executive Change: Perrigo has appointed Albert A. Manzone as interim president and CEO effective immediately, following the resignation of former CEO Patrick Lockwood-Taylor, indicating a swift leadership adjustment to address market challenges.
- Leadership Experience: Manzone has served on Perrigo's Board since 2022 and brings over 30 years of global leadership experience, providing essential strategic guidance and stability during the company's transition period.
- Financial Outlook Maintained: Perrigo reaffirms its 2026 financial outlook, projecting adjusted EPS between $2.00 and $2.30, and core adjusted EPS between $2.25 and $2.55, demonstrating the company's confidence in its future performance.
- Cost Savings Target: The company also reiterated its sales growth targets while aiming for $60 million to $80 million in cost savings, which will enhance profitability and support long-term growth strategies.
See More
Albert A. Manzone Appointed Interim CEO Following Lockwood-Taylor's Resignation
- Leadership Transition: Perrigo Company has appointed Albert A. Manzone as Interim CEO effective immediately following Patrick Lockwood-Taylor's resignation due to personal conduct deemed inconsistent with the company's values, although this conduct did not affect business operations or financial reporting.
- Board Confidence: The Board expresses full confidence in Manzone's leadership capabilities, citing his 30 years of global experience and business transformation expertise as critical for maintaining strategic stability during this transition and continuing value creation.
- 2026 Outlook Reaffirmed: Perrigo reaffirmed its 2026 financial outlook, projecting net sales growth between -5.5% and -1.5%, and adjusted EPS of $2.00 to $2.30, indicating clarity in financial goals despite the leadership change.
- Manzone's Priorities: As Interim CEO, Manzone emphasizes continuity of the company's strategy and support for the leadership team to sustain momentum in value creation, demonstrating his commitment to the company's future growth.
See More
Perrigo Appoints New Independent Directors
- New Board Members: Perrigo Company appointed Salman Amin and Omer Gajial as independent directors effective June 30, 2026, aiming to leverage their extensive experience in consumer products and retail to advance the company's strategic priorities.
- Salman Amin's Background: Amin has over 30 years of experience in the global consumer products industry, having served as CEO of pladis Global, where he successfully led a multi-year transformation that resulted in sustained revenue growth and improved profitability.
- Omer Gajial's Background: Gajial is currently the CEO of GoTo Foods, overseeing more than 7,000 restaurant and retail locations globally, and previously held the position of Executive Vice President at Albertsons Companies, focusing on merchandising and digital initiatives.
- Strategic Implications: The addition of these directors not only strengthens Perrigo's leadership in the consumer health sector but also enhances the company's strategic implementation in digital transformation and market growth, thereby improving overall operational efficiency.
See More
Perrigo Appoints New Independent Directors
- New Board Members: Perrigo Company announced the appointment of Salman Amin and Omer Gajial as independent directors effective June 30, 2026, aiming to leverage their extensive experience in consumer products and retail to advance the company's strategic priorities.
- Salman Amin's Background: Mr. Amin brings over 30 years of experience in the global consumer products industry, having served as CEO of pladis Global, where he successfully led a multi-year transformation that resulted in sustained revenue growth and improved profitability.
- Omer Gajial's Experience: Mr. Gajial, currently CEO of GoTo Foods, has extensive experience in retail and e-commerce, previously serving as Executive Vice President at Albertsons Companies, which positions him to provide strategic insights for Perrigo.
- Strategic Implications: The addition of these new directors not only strengthens Perrigo's leadership team but also aims to drive innovation and growth in the OTC self-care market, further solidifying its market position in North America and Europe.
See More
Stryker Shares Surge 5.3% on Analyst Upgrade and Growth Prospects
- Significant Price Surge: Stryker (SYK) shares rose 5.3% in the last trading session to close at $332.71, with trading volume significantly exceeding normal levels, reflecting renewed investor optimism regarding the company's long-term growth prospects.
- Analyst Upgrade: A recent upgrade to 'Outperform' by analysts has bolstered investor confidence, alongside management's reaffirmation of full-year guidance, indicating a recovery from temporary cyber disruptions.
- Strong Earnings Expectations: Stryker is expected to report quarterly earnings of $3.49 per share, representing an 11.5% year-over-year increase, with revenues projected at $6.56 billion, up 8.9%, highlighting the company's robust performance in the medical device sector.
- Earnings Estimate Revision: Although the consensus EPS estimate has been slightly revised lower, the correlation between earnings estimate trends and stock price movements suggests that investors should monitor SYK's future performance to determine if this price increase can be sustained.
See More
Market Analysis: Stock Performance and Investment Recommendations
- Stock Performance Analysis: Constellation Energy's stock has significantly declined, with analysts recommending a 'buy' as they believe the price has fallen too low, potentially offering a good entry point for investors.
- Investment Recommendation: Credo Technology is described as an 'excellent networking company,' with analysts suggesting to hold and gradually reduce cost basis, indicating its stock is on a rapid upward trajectory with substantial future potential.
- Market Sentiment: ManpowerGroup's performance has not been satisfactory, with analysts stating it has 'never really been a great win,' reflecting a lack of confidence in the company that may impact its future stock price.
- Value Trap Warning: Perrigo is viewed as a 'value trap,' with analysts noting a lack of growth potential and advising caution, which could lead to capital outflows from the stock.
See More
Perrigo Appoints New CEO to Maintain 2026 Outlook
- Executive Change: Perrigo has appointed Albert A. Manzone as interim president and CEO effective immediately, following the resignation of former CEO Patrick Lockwood-Taylor, indicating a swift leadership adjustment to address market challenges.
- Leadership Experience: Manzone has served on Perrigo's Board since 2022 and brings over 30 years of global leadership experience, providing essential strategic guidance and stability during the company's transition period.
- Financial Outlook Maintained: Perrigo reaffirms its 2026 financial outlook, projecting adjusted EPS between $2.00 and $2.30, and core adjusted EPS between $2.25 and $2.55, demonstrating the company's confidence in its future performance.
- Cost Savings Target: The company also reiterated its sales growth targets while aiming for $60 million to $80 million in cost savings, which will enhance profitability and support long-term growth strategies.
See More
Albert A. Manzone Appointed Interim CEO Following Lockwood-Taylor's Resignation
- Leadership Transition: Perrigo Company has appointed Albert A. Manzone as Interim CEO effective immediately following Patrick Lockwood-Taylor's resignation due to personal conduct deemed inconsistent with the company's values, although this conduct did not affect business operations or financial reporting.
- Board Confidence: The Board expresses full confidence in Manzone's leadership capabilities, citing his 30 years of global experience and business transformation expertise as critical for maintaining strategic stability during this transition and continuing value creation.
- 2026 Outlook Reaffirmed: Perrigo reaffirmed its 2026 financial outlook, projecting net sales growth between -5.5% and -1.5%, and adjusted EPS of $2.00 to $2.30, indicating clarity in financial goals despite the leadership change.
- Manzone's Priorities: As Interim CEO, Manzone emphasizes continuity of the company's strategy and support for the leadership team to sustain momentum in value creation, demonstrating his commitment to the company's future growth.
See More
